Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC02564 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | ICR.Cg-Nanos3<tm2(cre)Ysa>/27YsaRbrc |
Former Common name | Nanos3-CrepA(neo)#27 |
H-2 Haplotype | |
ES Cell line | TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1] |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | Nanos3 maintains the germ cell lineage in the mouse by suppressing both Bax-dependent and -independent apoptotic pathways. Suzuki H, Tsuda M, Kiso M, Saga Y Dev. Biol., 318, 133-142 (2008). 18436203 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 8 | Frt | ||||
Frt | yeast FRT (flippase recombination target) site | 8 | Frt | ||||
Nanos3 MGI:2675387 | nanos C2HC-type zinc finger 3 | 8 | Nanos3<tm2(cre)Ysa> MGI:3777592 | targeted mutation 2 (cre), Yumiko Saga | |||
cre | Phage P1 Cre recombinase | 8 | cre | ||||
neo | neomycin resistance gene (E. coli) | 8 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | phage P1 Cre recombinase, SV40 pA, yeast FRT (flipase recombination target) sites, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse Nanos3 genomic DNA |
Research application | Cre/loxP system Developmental Biology Research FLP/frt system |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Dev. Biol., 318, 133-142 (2008).Within a period of two years after deposition of the BIOLOGICAL RESOURCE, the RECIPIENT shall obtain a prior written consent on use of it from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR and notify him/her a content of the research. If the DEPOSITOR judges that the research should be a collaborative work, then the RECIPIENT must include the DEPOSITOR and/or the DEVELOPER's names as co-authors. |
Depositor | Yumiko Saga (National Institute of Genetics) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |